| P50 | author | Sahel Valadan Tahbaz | Q90184302 |
| P2093 | author name string | Mahla Asadian | |
| | Leila Azimi | |
| | Abdolaziz Rastegar Lari | |
| P2860 | cites work | Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis | Q47143645 |
| | Carbapenem Resistance: A Review. | Q53714289 |
| | The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. | Q54606682 |
| | Mechanisms of Antibiotic Resistance. | Q55387439 |
| | Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp | Q82967771 |
| | Two sequential outbreaks caused by multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 or OXA-72 oxacillinase in an intensive care unit in France | Q84694923 |
| | Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79) | Q87991284 |
| | Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran | Q88101022 |
| | Determination of antibiotic resistance pattern and prevalence of OXA-type carbapenemases among Acinetobacter baumannii clinical isolates from inpatients in Isfahan, central Iran | Q95485346 |
| | Carbapenems: past, present, and future | Q24634999 |
| | Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections | Q26991886 |
| | Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside | Q27024893 |
| | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance | Q29617469 |
| | Multidrug resistant Acinetobacter | Q33711902 |
| | Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea | Q33859045 |
| | Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii | Q33938042 |
| | Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe | Q34042289 |
| | Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections | Q34057525 |
| | The antibiotic resistance crisis: part 1: causes and threats | Q34471028 |
| | Burn wound infections | Q34647310 |
| | Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections | Q36095874 |
| | OXA-type carbapenemases | Q36381840 |
| | The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 |
| | A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii | Q36402290 |
| | First occurrence of bla OXA-58 in Acinetobacter baumannii isolated from a clinical sample in Southern Brazil | Q37160172 |
| | Spread of the blaOXA-23-Containing Tn2008 in Carbapenem-Resistant Acinetobacter baumannii Isolates Grouped in CC92 from China | Q37625333 |
| | Infection control in severely burned patients | Q37636650 |
| | Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin? | Q38405380 |
| | Evidence of Interruption of the comM Gene in a Large Series of Clinical Isolates of Multidrug-Resistant Acinetobacter baumannii | Q39387615 |
| | Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran | Q39475956 |
| | Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India | Q40576159 |
| | Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii | Q40862262 |
| | Limited genetic diversity and extensive antimicrobial resistance in clinical isolates of Acinetobacter baumannii in north-east Iran. | Q41215969 |
| | Clonal diversity and detection of carbapenem resistance encoding genes among multidrug-resistant Acinetobacter baumannii isolates recovered from patients and environment in two intensive care units in a Moroccan hospital | Q41670031 |
| | Characterization of a novel plasmid type and various genetic contexts of bla OXA-58 in Acinetobacter spp. from multiple cities in China | Q41853577 |
| | High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial | Q41992993 |
| | Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. | Q42245819 |
| | Carbapenem resistance in Acinetobacter baumannii: where is it heading? | Q42248679 |
| | Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii | Q42257559 |
| | Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. | Q43257735 |
| | In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii. | Q46528095 |
| P921 | main subject | meropenem | Q421670 |
| | multiple drug resistance | Q643839 |
| | Acinetobacter baumannii | Q3241189 |
| P304 | page(s) | Doc08 | |
| P577 | publication date | 2019-08-02 | |
| P1433 | published in | GMS hygiene and infection control | Q27724858 |
| P1476 | title | Evaluation of synergistic effect of tazobactam with meropenem and ciprofloxacin against multi-drug resistant Acinetobacter baumannii isolated from burn patients in Tehran | |
| P478 | volume | 14 | |